However, a recent study showed that global or microglia‐specific deletion of Trpv4 increases microglial phagocytic activity, but has no impact on disease severity and myelin damage extent in EAE and cuprozone‐induced demyelination MS models [141]. The gene discussed is TRPV4; the disease is myeloid sarcoma.